Thus, we suspected that this capability of p53 to suppress angiogenesis may be one reason that p53 is frequently inactivated in PDAC already deficient in function of the P16/INK4A and P14/ARF tumor suppressors. The gene discussed is CDKN2A; the disease is neoplasm.